As of 2024-12-15, the EV/EBITDA ratio of SpectraCure AB (publ) (SPEC.ST) is -14.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SPEC.ST's latest enterprise value is 270.87 mil SEK. SPEC.ST's TTM EBITDA according to its financial statements is -19.10 mil SEK. Dividing these 2 quantities gives us the above SPEC.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.8x - 10.8x | 9.2x |
| Forward P/E multiples | 9.1x - 11.9x | 9.8x |
| Fair Price | (1.49) - (1.82) | (1.56) |
| Upside | -148.1% - -158.9% | -150.3% |
| Date | EV/EBITDA |
| 2024-12-12 | -12.17 |
| 2024-12-11 | -10.57 |
| 2024-12-10 | -5.04 |
| 2024-12-09 | -3.62 |
| 2024-12-06 | -4.35 |
| 2024-12-05 | -4.99 |
| 2024-12-04 | -4.64 |
| 2024-12-03 | -4.53 |
| 2024-12-02 | -4.63 |
| 2024-11-29 | -5.81 |
| 2024-11-28 | -5.78 |
| 2024-11-27 | -6.31 |
| 2024-11-26 | -6.82 |
| 2024-11-25 | -7.03 |
| 2024-11-22 | -6.81 |
| 2024-11-21 | -6.49 |
| 2024-11-20 | -6.68 |
| 2024-11-19 | -6.56 |
| 2024-11-18 | -6.72 |
| 2024-11-15 | -6.88 |
| 2024-11-14 | -7.09 |
| 2024-11-13 | -5.72 |
| 2024-11-12 | -5.57 |
| 2024-11-11 | -5.72 |
| 2024-11-08 | -6.58 |
| 2024-11-07 | -5.26 |
| 2024-11-06 | -5.12 |
| 2024-11-05 | -5.51 |
| 2024-11-04 | -6.25 |
| 2024-11-01 | -6.57 |
| 2024-10-31 | -6.88 |
| 2024-10-30 | -7.31 |
| 2024-10-29 | -7.48 |
| 2024-10-28 | -7.71 |
| 2024-10-25 | -7.85 |
| 2024-10-24 | -8.08 |
| 2024-10-23 | -7.28 |
| 2024-10-22 | -7.74 |
| 2024-10-21 | -7.84 |
| 2024-10-18 | -8.30 |
| 2024-10-17 | -8.51 |
| 2024-10-16 | -8.41 |
| 2024-10-15 | -8.57 |
| 2024-10-14 | -8.69 |
| 2024-10-11 | -8.87 |
| 2024-10-10 | -8.53 |
| 2024-10-09 | -8.64 |
| 2024-10-08 | -8.76 |
| 2024-10-07 | -8.79 |
| 2024-10-04 | -8.74 |